Cytokinetics
NASDAQ: CYTKSouth San Francisco, US · Founded 1998 · 798 employees on LinkedIn · 1 known investors
Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.
Founders & leadership
Cytokinetics was founded in 1998 by James Spudich, Ronald Vale, and Lawrence S.B. Goldstein.
Board
JS
James Sabry
Investors · 1
Founder mafia
2 people who came through Cytokinetics went on to found or lead other companies.
In the news
How Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss - Simply Wall St Newssimplywall.st · Aug 2026Frequently asked questions
- What does Cytokinetics do?
- Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.
- Who founded Cytokinetics?
- Cytokinetics was founded by James Spudich, Ronald Vale, Lawrence S.B. Goldstein in 1998.
- Who are Cytokinetics's investors?
- Cytokinetics's investors include Foresite Capital.
- Where is Cytokinetics headquartered?
- Cytokinetics is headquartered in South San Francisco, US.